Alx Oncology Holdings INC (ALXO) SEC Filings — 2025

Filings

• ALX Oncology Narrows Q3 Loss Amidst R&D Cost Cuts — 10-Q · Nov 7, 2025
• ALX Oncology Files 8-K: Director Changes and Officer Appointments — 8-K · Sep 12, 2025
• ALX Oncology Narrows Q2 Loss by 34% Amid R&D Spend Cuts — 10-Q · Aug 12, 2025
• ALX Oncology Holdings Inc. Files 8-K on Shareholder Vote Matters — 8-K · Jun 12, 2025
• ALX Oncology Files Q1 2025 10-Q — 10-Q · May 8, 2025
• ALX Oncology Faces Delisting Notice — 8-K · Apr 25, 2025
• ALX Oncology Executive Compensation Details Revealed — DEF 14A · Apr 21, 2025
• ALX Oncology Files 8-K for Financials — 8-K · Mar 6, 2025
• ALX Oncology Reports Exit Costs and Officer Changes — 8-K · Mar 5, 2025
• ALX Oncology Holdings Inc. Files 8-K with Board and Compensation Changes — 8-K · Jan 22, 2025
• ALX Oncology Holdings Inc. Reports Board and Executive Changes — 8-K · Jan 17, 2025